Genetic Inhibition of APOL1 Pore Forming Function Prevents APOL1 Kidney Disease

被引：0
|
作者：
Hung, Adriana [1 ,2 ]
Assimon, Victoria [3 ]
Chen, Hua-Chang [1 ,2 ]
Yu, Zhihong [1 ,2 ]
Tao, Ran [1 ,2 ]
Siew, Edward D. [1 ,2 ]
Susztak, Katalin [4 ,5 ]
Graham, Robert R. [3 ]
Hoek, Maarten [3 ]
Robinson-Cohen, Cassianne [2 ]
Green, Eric [3 ]
Bick, Alexander [2 ]
机构：
[1] VA Tennessee Valley Healthcare Syst, Nashville, TN USA
[2] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[3] MAZE Therapeut, San Francisco, CA USA
[4] Philadelphia VA Med Ctr, Philadelphia, PA USA
[5] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
FR-PO316
引用
收藏
页码：411 / 411
页数：1
相关论文
共 50 条
  • [41] The Cell Biology of APOL1
    O'Toole, John F.
    Bruggeman, Leslie A.
    Madhavan, Sethu
    Sedor, John R.
    SEMINARS IN NEPHROLOGY, 2017, 37 (06) : 538 - 545
  • [42] APOL1 polymorphisms and kidney disease: loss-of-function or gain-of-function?
    Bruggeman, Leslie A.
    O'Toole, John F.
    Sedor, John R.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2019, 316 (01) : F1 - F8
  • [43] The Mechanism of Kidney Disease due to APOL1 Risk Variants
    Pays, Etienne
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (06): : 818 - 821
  • [44] APOL1 and Cardiovascular Disease A Story in Evolution
    Bajaj, Archna
    Susztak, Katalin
    Damrauer, Scott M.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37 (09) : 1587 - 1589
  • [45] The Mechanism of Kidney Disease Due to APOL1 Risk Variants
    Pays, Etienne
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 31 (11): : 2502 - 2505
  • [46] APOL1 risk variants drive kidney disease in mice
    Susan J. Allison
    Nature Reviews Nephrology, 2017, 13 : 259 - 259
  • [47] APOL1 genotyping in kidney transplantation: a look into the future
    Madhavan, Sethu M.
    KIDNEY INTERNATIONAL, 2021, 100 (01) : 32 - 34
  • [48] Ten years in: APOL1 reaches beyond the kidney
    Waitzman, Joshua S.
    Lin, Jennie
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2019, 28 (04): : 375 - 382
  • [49] Small molecule APOL1 inhibitors as a precision medicine approach for APOL1-mediated kidney disease
    Zimmerman, Brandon
    Dakin, Leslie A.
    Fortier, Anne
    Nanou, Evanthia
    Blasio, Angelo
    Mann, James
    Miller, Howard
    Fletcher, Marissa
    Wang, Tiansheng
    Nanthakumar, Suganthini
    Mccarthy, Gizelle
    Matar, Caline
    Matsye, Prachi
    Wang, Guanyu
    Snyder, Phillip
    Daniel, Kevin
    Swamy, Harsha
    Sullivan, Kelly
    Bright, Franklin
    Powers, Audrey
    Gagnon, Kevin J.
    Lu, Fan
    Paula, Steven
    Khare-Pandit, Suvarna
    Henry, Larry
    Hamel, Martine
    Denis, Francois
    Nicolas, Olivier
    Hariparsad, Niresh
    Kumar, Shyamesh
    Proctor, Jennifer
    Senter, Timothy
    Furey, Brinley
    Bunnage, Mark E.
    NATURE COMMUNICATIONS, 2025, 16 (01)
  • [50] Genetics of kidney failure and the evolving story of APOL1
    Friedman, David J.
    Pollak, Martin R.
    JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (09): : 3367 - 3374
12345